Estonia vs United States of America: Treatment success rate for patients treated for MDR-TB
Estonia
88.0%
in 2022
United States of America
87.0%
in 2021
Estonia rank
26th
United States of America rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Estonia
- United States of America
How they compare
Estonia currently reports 88.0% against 87.0% in United States of America, a difference of 1.0%.
The two have swapped places 5 times across 15 shared years of data; in 2007 it was United States of America ahead.
Estonia ranks 26th and United States of America ranks 27th of 163 countries.
Across the 3 decades both report, Estonia averaged higher in 1 and United States of America in 2.
Head to head by decade
| Decade | Estonia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 71.7% | 25.7% | United States of America |
| 2010s | 71.6% | 74.9% | 3.3% | United States of America |
| 2020s | 84.0% | 83.5% | 0.5% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Estonia or United States of America?
- Estonia, at 88.0% against 87.0% in United States of America as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Estonia and United States of America?
- 1.0%, with Estonia ahead.
- How many years of comparable data are there for Estonia and United States of America?
- 15 years are reported by both, from 2007 to 2021.
- How do Estonia and United States of America rank globally for treatment success rate for patients treated for mdr-tb?
- Estonia ranks 26th and United States of America ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.